Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Total Assets 2016–2025
Ultragenyx Pharmaceutical Inc. annual total assets history from 2016 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Ultragenyx Pharmaceutical Inc. total assets as of December 31, 2025: 1.53B, a 1.93% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. total assets for 2025 were 1.53B, a 1.93% increase from 2024.
- Ultragenyx Pharmaceutical Inc. total assets for 2024 were 1.50B, a 0.80% increase from 2023.
- Ultragenyx Pharmaceutical Inc. total assets for 2023 were 1.49B, a 3.52% decrease from 2022.
- Ultragenyx Pharmaceutical Inc. total assets for 2022 were 1.55B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ultragenyx Pharmaceutical Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $1,532 |
| 2024 | $1,503 |
| 2023 | $1,491 |
| 2022 | $1,545 |
| 2021 | $1,522 |
| 2020 | $1,760 |
| 2019 | $1,135 |
| 2018 | $720 |
| 2017 | $491 |
| 2016 | $541 |
Ultragenyx Pharmaceutical Inc. Total Assets — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) total assets over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's total assets history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s total assets by year and by quarter, including the growth rate.